bpc 157 esophagus JPP No 3/2018 article 11 BPC-157 for GERD: Healing Esophagus

Mechanism of Action ARA-290 has been investigated for its selective activation of the innate repair receptor (IRR), a heterodimeric complex composed of the EPO receptor and beta common receptor (CD131)

Heres where current clinical use is most common: Not all peptide therapy looks the same

These neuroregeneration studies have established BPC-157 as a research tool with broad CNS biology relevance extending beyond its gastrointestinal and musculoskeletal repair applications

There is mention of different medications, including heartworm prevention and daily medications

Discussions typically include dosing strategies, duration of therapy, and regulatory considerations, as these peptides are not FDA-approved for all uses and may be considered investigational

Neither compound is approved by the FDA for human or veterinary therapeutic use